Diassess is a US-based in vitro diagnostics company that provides disposable infectious disease tests for use at home. Founded in 2013, the company has developed a platform technology capable of DNA/RNA detection in a non-instrumented format. Through their diagnostic test and companion mobile app, Diassess will enable patients to receive treatment faster than ever before, without a visit to the physician’s office. The company has received funding from the NIH, NSF and BARDA to develop their technology and launch assays for influenza and sexually transmitted infections.